There remain for many people questions about Provenge. The most common question I hear is about the financial cost of the treatment for what has been described as “only 4 months of life extension for $93,000, is it worth it?” Well, the answer is a clear yes! […]
The Food and Drug Administration (FDA) has announced that it is looking into reports that Glaxo Smith Kline’s prostate drug Avodart and Merck & Co’s prostate drug Proscar may be contributing to an increase of male breast cancers. […]
Using a CTC-chip that measures the level of circulating tumor cells in blood can provide an important insight into the prognosis and potential rates of recurrent disease, according to data from a developing study at Massachusetts General Hospital, which was presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010. [...]
Join and participate in my new facebook "wiki" page called ADVANCED PROSTATE CANCER.
I have been reading in the press about a recent medical malpractice settlement surrounding prostate cancer. Briefly, a man went to his primary care physician who, along with other tests, performed a DRE and PSA test. The doctor failed to inform his patient about the negative test results which were indicative of a diagnosis of [...]